XOMA Corp (XOMA.OQ)

XOMA.OQ on NASDAQ Stock Exchange Global Market

5.43USD
10:55am EDT
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.43
Open
$5.49
Day's High
$5.49
Day's Low
$5.39
Volume
37,650
Avg. Vol
227,116
52-wk High
$5.53
52-wk Low
$2.37

XOMA.OQ

Chart for XOMA.OQ

About

XOMA Corporation (XOMA) is engaged in the discovery and development of antibody-based therapeutics. The Company’s lead drug candidate is gevokizumab (formerly XOMA 052), a humanized monoclonal allosteric modulating antibody designed to inhibit the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta). The Company’s preclinica... (more)

Overall

Beta: 2.26
Market Cap (Mil.): $450.11
Shares Outstanding (Mil.): 82.89
Dividend: --
Yield (%): --

Financials

  XOMA.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -0.90 -- --
ROI: -86.05 -2.58 18.76
ROE: -705.39 -2.66 19.59
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$58.00
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$495.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks